UCB reports positive outcomes for bimekizumab in psoriatic arthritis

19th May 2026 Uncategorised 0

Trial shows first head‑to‑head superiority in joint endpoints for an approved PsA biologic

More: UCB reports positive outcomes for bimekizumab in psoriatic arthritis
Source: News